Announcement
Appointment of Chief Manufacturing & Operations Officer
Paiania, September 3, 2026 - LAVIPHARM S.A. announces the appointment of Mr. Anastasios Spyropoulos as Chief Manufacturing & Operations Officer.
Mr. Spyropoulos is a Chemical Engineer (BEng, University of Leeds) with postgraduate studies at the National Technical University of Athens. He brings more than 20 years of experience in the pharmaceutical industry, with a leadership track record in Industrial Operations and Supply Chain and specialized expertise in the manufacturing of sterile products and solid dosage forms.
His experience spans the management of production facilities, the execution of major investment projects and the implementation of operational excellence programs. He joins from the Pharmathen Group, where he served as Vice President, Industrial Operations, Attica Sites.
This announcement is issued in accordance with the provisions of the Athens Stock Exchange Rulebook, Law 3556/2007, and Regulation (EU) 596/2014 (MAR).
For further information:
Corporate Communications
Vivienne Thomas
Tel: +30 210 6691404
[email protected]